Gilad Oren

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$20,233.50
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Gilad Oren

According to the SEC Form 4 filings, Gilad Oren, being in a position of

  1. President/CEO at Aprea Therapeutics, Inc.,
    оver the last 12 months, has bought 3900 shares for $20,234, and sold 0 shares,
    over all time since 2024-03-13, has bought 3900 shares for $20,234, and sold 0 shares.

The largest purchase of all time was on 2024-03-13 and amounted to 2000 shares of Aprea Therapeutics, Inc. for $14,580.

Biography of Gilad Oren

No biography is available at this moment.

2024-10-23PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
500
0.0086%
$3.92$1,9580%
2024-10-15PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
250
0.0046%
$2.90$725+31.48%
2024-10-14PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
1,000
0.0163%
$2.59$2,590+55.86%
2024-10-10PurchaseAprea Therapeutics, Inc.
APRE
President/CEO
150
0.0024%
$2.54$381+55.31%
2024-03-13PurchaseAprea Therapeutics, Inc.
APRE
President, CEO
2,000
0.0683%
$7.29$14,580-22.97%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.